Alzamend Neuro (ALZN) Invested Capital (2020 - 2024)

Alzamend Neuro has disclosed Invested Capital across 4 years of filings, most recently posting -$2.3 million for Q2 2024.

• In Q2 2024, Invested Capital changed N/A year-over-year to -$2.3 million; the TTM figure through Apr 2024 stood at -$2.3 million (changed N/A YoY), while the FY2024 annual figure was -$2.3 million, changed N/A from the prior year.
• Invested Capital came in at -$2.3 million for Q2 2024 at Alzamend Neuro, down from $9.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $15.4 million in Q3 2021 to a low of -$2.3 million in Q2 2024.
• Average Invested Capital over 4 years is $8.0 million, with a median of $10.9 million recorded in 2022.
• The largest YoY upside for Invested Capital was 543.95% in 2022 against a maximum downside of 24.95% in 2022.
• Over 4 years, Invested Capital stood at $884376.0 in 2020, then surged by 1373.08% to $13.0 million in 2021, then retreated by 24.95% to $9.8 million in 2022, then plunged by 123.46% to -$2.3 million in 2024.
• Per Business Quant data, the three most recent Invested Capital figures were -$2.3 million in Q2 2024, $9.8 million in Q4 2022, and $13.4 million in Q2 2022.